Sabra Health Care REIT Inc
XBER:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sabra Health Care REIT Inc
XBER:SBC
|
US |
|
I
|
Inchcape PLC
F:IJCA
|
UK |
|
New Oriental Education & Technology Group Inc
LSE:0K75
|
CN |
|
J
|
JCDecaux SA
F:DCS
|
FR |
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
T
|
TransAlta Corp
F:TZ1
|
CA |
|
S
|
Swiss Re AG
SWB:SR9
|
CH |
Wall St Price Targets
SBC Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for SBC is 18.99 EUR with a low forecast of 17.15 EUR and a high forecast of 21.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SBC's stock price target?
Price Target
18.99
EUR
According to Wall Street analysts, the average 1-year price target for SBC is 18.99 EUR with a low forecast of 17.15 EUR and a high forecast of 21.4 EUR.
What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.
What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 6 years is 13%.
What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 10%.
